RM Krauss - Diabetes Care, 2004 - Am Diabetes Assoc Insulin resistance and type 2 diabetes are associated with a clustering of
interrelated plasma lipid and lipoprotein abnormalities, which include reduced
HDL cholesterol, a predominance of small dense LDL particles, and elevated ... Cited by 181 - Related articles - BL Direct - All 6 versions
RM Krauss, PW Siri - Medical Clinics of North America, 2004 - Elsevier The cluster of lipid abnormalities associated with type 2 diabetes is defined by
increases in triglyceride (TG) and small, dense low-density lipoprotein (LDL)
concentrations and decreases in high-density lipoprotein (HDL) cholesterol. ... Cited by 21 - Related articles - BL Direct - All 3 versions
- ►diabetesjournals.org WT Garvey, S Kwon, D Zheng, S Shaughnessy, … - Diabetes, 2003 - Am Diabetes Assoc The insulin resistance syndrome (IRS) is associated with dyslipidemia and
increased cardiovascular disease risk. A novel method for detailed analyses of
lipoprotein subclass sizes and particle concentrations that uses nuclear ... Cited by 169 - Related articles - BL Direct - All 4 versions
RB Goldberg, DM Kendall, MA Deeg, JB Buse, … - Diabetes care, 2005 - Am Diabetes Assoc RESEARCH DESIGN AND METHODS—We enrolled subjects with a diagnosis of type 2
diabetes (treated with diet alone or oral monotherapy) and dyslipidemia (not
treated with any lipid-lowering agents). After a 4-week placebo washout ... Cited by 334 - Related articles - BL Direct - All 13 versions
LOWDL SIZE - Handbook of lipoprotein testing, 2000 - books.google.com Measurement and Clinical Significance of Low-Density Lipoprotein Subclasses John
E. Hokanson -0-Low-density lipoprotein (LDL) heterogeneity has been recognized
for many years. 1-4 There is now convincing evidence of a relationship ... Related articles
E Chiquette, G Ramirez, R DeFronzo - Archives of internal medicine, 2004 - archinte.highwire.org You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Add to CiteULike Add to ... Cited by 196 - Related articles - BL Direct - All 6 versions
K Berneis, C Jeanneret, J Muser, B Felix, AR … - Metabolism, 2005 - Elsevier The atherogenic lipoprotein phenotype is characterized by an increase in plasma
triglycerides, a decrease in high-density lipoprotein (HDL), and the prevalence
of small, dense low-density lipoprotein (LDL) particles. The present study ... Cited by 41 - Related articles - All 11 versions
- ►ahajournals.org JPH van Wijk, EJP de Koning, EP Martens, TJ … - Arteriosclerosis, thrombosis, and vascular biology, 2003 - Am Heart Assoc We evaluated study population characteristics and treatment effects on blood
lipids between studies in which either rosiglitazone (RSG) or pioglitazone (PIO)
was investigated in patients with type 2 diabetes. We performed a summary ... Cited by 130 - Related articles - BL Direct - All 7 versions
- ►endojournals.org FM Sacks, H Campos - Journal of Clinical Endocrinology & Metabolism, 2003 - Endocrine Soc The major lipoprotein types, very low-density lipoprotein (VLDL), low-density
lipoprotein (LDL), and high-density lipoprotein (HDL), are composed of many
subgroups (1, 2, 3). Classifications are based on size (1), density, or ... Cited by 52 - Related articles - All 2 versions
WC Cromwell, JD Otvos - Current atherosclerosis reports, 2004 - Springer Introduction The key role played by low-density lipoprotein (LDL) parti- cles in
the pathogenesis of coronary heart disease (CHD) is well accepted, as is the
public health benefit of lowering LDL in high-risk patients. What remains ... Cited by 87 - Related articles - All 3 versions
